المؤلفون: Kibel S; Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 3H2, Canada.; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada., Kuehne N; Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 3H2, Canada.; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada., Ribeiro MF; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada., Muniz TP; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada., Ye XY; Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada., Spreafico A; Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 3H2, Canada.; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada., Saibil SD; Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 3H2, Canada.; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada., Sun A; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada., Mak DY; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada., Gray D; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada., Jones B; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada., Wong P; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada., Butler MO; Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 3H2, Canada.; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada.; Department of Immunology, University of Toronto, Toronto, ON M5S 3H2, Canada.

المصدر: Cancers [Cancers (Basel)] 2023 Dec 16; Vol. 15 (24). Date of Electronic Publication: 2023 Dec 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Koch Hein EC; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada.; Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, ON M5S 1A8, Canada.; Department of Hematology and Oncology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8331150, Chile., Vilbert M; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada.; Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, ON M5S 1A8, Canada., Hirsch I; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada.; Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, ON M5S 1A8, Canada., Fernando Ribeiro M; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada.; Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, ON M5S 1A8, Canada., Muniz TP; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada.; Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, ON M5S 1A8, Canada., Fournier C; Department of Medicine, Division of Dermatology, University of Toronto, Toronto, ON M5S 1A8, Canada.; Dermatology Service, Hôtel-Dieu-de-Lévis, Lévis, QC G6V 3Z1, Canada., Abdulalem K; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada.; Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, ON M5S 1A8, Canada., Saldanha EF; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada.; Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, ON M5S 1A8, Canada., Martinez E; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada.; Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, ON M5S 1A8, Canada., Spreafico A; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada.; Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, ON M5S 1A8, Canada., Hogg DH; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada.; Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, ON M5S 1A8, Canada., Butler MO; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada.; Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, ON M5S 1A8, Canada., Saibil SD; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada.; Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, ON M5S 1A8, Canada.

المصدر: Cancers [Cancers (Basel)] 2023 Aug 29; Vol. 15 (17). Date of Electronic Publication: 2023 Aug 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Muniz TP; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada. thiago.muniz@uhn.ca., Mason WP; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada.

المصدر: CNS drugs [CNS Drugs] 2023 Jul; Vol. 37 (7), pp. 587-598. Date of Electronic Publication: 2023 Jun 02.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9431220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1934 (Electronic) Linking ISSN: 11727047 NLM ISO Abbreviation: CNS Drugs Subsets: MEDLINE

مواضيع طبية MeSH: Brain Neoplasms*/drug therapy , Brain Neoplasms*/genetics , Brain Neoplasms*/pathology , Glioma*/drug therapy , Glioma*/genetics , Central Nervous System Neoplasms*/drug therapy , Central Nervous System Neoplasms*/genetics, Humans ; Proto-Oncogene Proteins B-raf/genetics ; Proto-Oncogene Proteins B-raf/therapeutic use ; Prognosis ; Retrospective Studies ; Mutation ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use

المؤلفون: Arteaga Ceballos DP; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.; Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, Canada., Saeed-Kamil Z; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada., King I; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.; Division of Clinical Laboratory Genetics, Laboratory Medicine Program, University Health Network, Toronto, Canada., Stockley T; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.; Division of Clinical Laboratory Genetics, Laboratory Medicine Program, University Health Network, Toronto, Canada., Liu D; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada., Muniz TP; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.; Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, Canada., Saibil SD; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.; Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, Canada.; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada., Hogg D; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.; Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, Canada., Spreafico A; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.; Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, Canada.; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada., Butler MO; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.; Department of Medicine, Division of Medical Oncology, University of Toronto, Toronto, Canada.; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

المصدر: JCO oncology practice [JCO Oncol Pract] 2022 May; Vol. 18 (5), pp. e642-e647. Date of Electronic Publication: 2022 Apr 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/drug therapy , Melanoma*/genetics , Melanoma*/pathology , Skin Neoplasms*/drug therapy, Adult ; Humans ; Proto-Oncogene Proteins B-raf/genetics ; Proto-Oncogene Proteins B-raf/therapeutic use ; Retrospective Studies ; Tertiary Healthcare

المؤلفون: Muniz TP; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, University Health Network, Toronto, ON M5S 1Z5, Canada., Araujo DV; Hospital de Base, Faculdade de Medicina de Sao Jose do Rio Preto, Sao Jose do Rio Preto 15090-000, Brazil., Savage KJ; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC V5Z 1M9, Canada., Cheng T; Department of Oncology, University of Calgary, Calgary, AB T2N 4N2, Canada., Saha M; Division of Endocrinology and Metabolism, University of British Columbia, Vancouver, BC V6Z 1Y6, Canada., Song X; The Ottawa Hospital Cancer Centre, University of Ottawa, Ottawa, ON K1H 8L6, Canada., Gill S; Division of Endocrinology and Metabolism, University of British Columbia, Vancouver, BC V6Z 1Y6, Canada., Monzon JG; Department of Oncology, University of Calgary, Calgary, AB T2N 4N2, Canada., Grenier D; Department of Medical Oncology, University of Manitoba, Winnipeg, MB R3A 1R9, Canada., Genta S; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, University Health Network, Toronto, ON M5S 1Z5, Canada., Allen MJ; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, University Health Network, Toronto, ON M5S 1Z5, Canada., Arteaga DP; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, University Health Network, Toronto, ON M5S 1Z5, Canada., Saibil SD; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, University Health Network, Toronto, ON M5S 1Z5, Canada., Butler MO; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, University Health Network, Toronto, ON M5S 1Z5, Canada., Spreafico A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, University Health Network, Toronto, ON M5S 1Z5, Canada., Hogg D; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, University Health Network, Toronto, ON M5S 1Z5, Canada.

المصدر: Cancers [Cancers (Basel)] 2021 Dec 24; Vol. 14 (1). Date of Electronic Publication: 2021 Dec 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Muniz TP; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada. Electronic address: thiago.muniz@uhn.ca., Sorotsky H; Institute of Oncology, Chaim Sheba Medical Center at Tel-Hashomer, Ramant Gan, Israel., Kanjanapan Y; Department of Medical Oncology, Canberra Region Cancer Centre, Canberra, Australia., Rose AAN; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada; Gerald Bronfman Department of Oncology, Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada; Segal Cancer Centre, Jewish General Hospital, Montreal, Quebec, Canada., Araujo DV; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada; Department of Medical Oncology, Hospital de Base, Sao Jose do Rio Preto, Brazil., Fortuna A; Translational Genomics Laboratory, Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Ghazarian D; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada; Department of Laboratory Medicine & Pathobiology, University Health Network, University of Toronto, Toronto, Ontario, Canada., Kamil ZS; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada; Department of Laboratory Medicine & Pathobiology, University Health Network, University of Toronto, Toronto, Ontario, Canada., Pugh T; Translational Genomics Laboratory, Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Mah M; Translational Genomics Laboratory, Ontario Institute for Cancer Research, Toronto, Ontario, Canada; Trillium Health Partners, Genetics Laboratory, Mississauga, Ontario, Canada., Thiagarajah M; Translational Genomics Laboratory, Ontario Institute for Cancer Research, Toronto, Ontario, Canada; Department of Laboratory Medicine, Unity Health Toronto, Toronto, Ontario, Canada., Torti D; Translational Genomics Laboratory, Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Spreafico A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada; Phase 1 Drug Development Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Hogg D; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.

المصدر: The Journal of investigative dermatology [J Invest Dermatol] 2021 Oct; Vol. 141 (10), pp. 2470-2479. Date of Electronic Publication: 2021 Apr 06.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1747 (Electronic) Linking ISSN: 0022202X NLM ISO Abbreviation: J Invest Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma/*genetics , Nerve Sheath Neoplasms/*genetics , Skin Neoplasms/*genetics, Adult ; Aged ; Antigens, Neoplasm/genetics ; DNA Copy Number Variations ; DNA-Binding Proteins/genetics ; Female ; Genes, ras ; Genomics ; Humans ; MAP Kinase Signaling System ; Male ; Melanoma/pathology ; Middle Aged ; Neoplasm Proteins/genetics ; Nerve Sheath Neoplasms/pathology ; Retrospective Studies ; Serpins/genetics

المؤلفون: Muniz TP; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada thiago.muniz@uhn.ca., Patriquin CJ; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Saibil SD; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

المصدر: BMJ case reports [BMJ Case Rep] 2021 Jul 26; Vol. 14 (7). Date of Electronic Publication: 2021 Jul 26.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 101526291 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-790X (Electronic) Linking ISSN: 1757790X NLM ISO Abbreviation: BMJ Case Rep Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/drug therapy , Thrombotic Microangiopathies*/chemically induced, Aged ; Complement Inactivating Agents ; Humans ; Ipilimumab/adverse effects ; Male ; Nivolumab/adverse effects

المؤلفون: Kelly D; Princess Margaret Cancer Center, Division of Medical Oncology and Hematology, University Health Network, Toronto, ON M5G1Z5, Canada., Rose AAN; Princess Margaret Cancer Center, Division of Medical Oncology and Hematology, University Health Network, Toronto, ON M5G1Z5, Canada.; Department of Oncology, McGill University, Montreal, QC H3A1G5, Canada.; Segal Cancer Centre & Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC H3T1E2, Canada., Muniz TP; Princess Margaret Cancer Center, Division of Medical Oncology and Hematology, University Health Network, Toronto, ON M5G1Z5, Canada., Hogg D; Princess Margaret Cancer Center, Division of Medical Oncology and Hematology, University Health Network, Toronto, ON M5G1Z5, Canada., Butler MO; Princess Margaret Cancer Center, Division of Medical Oncology and Hematology, University Health Network, Toronto, ON M5G1Z5, Canada.; Princess Margaret Cancer Center, Tumor Immunotherapy Program, Toronto, ON M5G1Z5, Canada., Saibil SD; Princess Margaret Cancer Center, Division of Medical Oncology and Hematology, University Health Network, Toronto, ON M5G1Z5, Canada.; Princess Margaret Cancer Center, Tumor Immunotherapy Program, Toronto, ON M5G1Z5, Canada., King I; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5G1Z5, Canada.; Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G1Z5, Canada., Kamil ZS; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5G1Z5, Canada.; Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G1Z5, Canada., Ghazarian D; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5G1Z5, Canada.; Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G1Z5, Canada., Ross K; Princess Margaret Cancer Center, Tumor Immunotherapy Program, Toronto, ON M5G1Z5, Canada., Iafolla M; Princess Margaret Cancer Center, Division of Medical Oncology and Hematology, University Health Network, Toronto, ON M5G1Z5, Canada.; Princess Margaret Cancer Center, Tumor Immunotherapy Program, Toronto, ON M5G1Z5, Canada., Araujo DV; Princess Margaret Cancer Center, Division of Medical Oncology and Hematology, University Health Network, Toronto, ON M5G1Z5, Canada.; Department of Medical Oncology, Hospital de Base, Sao Jose do Rio Preto 15090-000, SP, Brazil., Waldron J; Princess Margaret Cancer Centre, Department of Radiation Oncology, University of Toronto, Toronto, ON M5G1Z5, Canada., Laperriere N; Princess Margaret Cancer Centre, Department of Radiation Oncology, University of Toronto, Toronto, ON M5G1Z5, Canada., Krema H; Princess Margaret Cancer Centre, Ocular Oncology Service Krembil Research Institute, University Health Network, Toronto, ON M5G2C1, Canada., Spreafico A; Princess Margaret Cancer Center, Division of Medical Oncology and Hematology, University Health Network, Toronto, ON M5G1Z5, Canada.; Princess Margaret Cancer Center, Tumor Immunotherapy Program, Toronto, ON M5G1Z5, Canada.

المصدر: Cancers [Cancers (Basel)] 2021 Jul 20; Vol. 13 (14). Date of Electronic Publication: 2021 Jul 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Araujo DV; Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, ON M5G 1X6, Canada.; Department of Medical Oncology, Hospital de Base, Sao Jose do Rio Preto 15090 000, Brazil., Muniz TP; Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, ON M5G 1X6, Canada., Yang A; Department of Pharmacy, University Health Network, Toronto, ON M5G 2M9, Canada., Keshavarzi S; Department of Biostatistics, Princess Margaret Cancer Center, Toronto, ON M5G 2M9, Canada.; Biostatistics Division, Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5T 3M7, Canada., Sorotsky H; Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, ON M5G 1X6, Canada.; Cancer Center, Chaim Sheba Medical Center at Tel HaShomer, Ramat Gan 52621, Israel., Butler MO; Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, ON M5G 1X6, Canada., Saibil S; Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, ON M5G 1X6, Canada., Spreafico A; Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, ON M5G 1X6, Canada., Hogg D; Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, ON M5G 1X6, Canada.

المصدر: Current oncology (Toronto, Ont.) [Curr Oncol] 2021 Jun 11; Vol. 28 (3), pp. 2173-2179. Date of Electronic Publication: 2021 Jun 11.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729 (Electronic) Linking ISSN: 11980052 NLM ISO Abbreviation: Curr Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Chemical and Drug Induced Liver Injury*/etiology , Steroids*, Aged ; Aged, 80 and over ; Humans ; Infliximab/adverse effects ; Middle Aged ; Retrospective Studies

عنوان ترانسليتريتد: Da busca pelo diagnóstico às incertezas do tratamento: desafios do cuidado para as doenças genéticas raras no Brasil.

المؤلفون: Iriart JAB; Instituto de Saúde Coletiva, Universidade Federal da Bahia. R. Basílio da Gama s/n, Canela. 40110-040. Salvador, BA, Brasil. iriart@ufba.br., Nucci MF; Casa de Oswaldo Cruz, Fiocruz. Rio de Janeiro,  RJ, Brasil., Muniz TP; Universidade Federal do Rio Grande do Sul. Porto Alegre, RS, Brasil., Viana GB; Programa de Pós-Graduação em Ciências Sociais, Universidade Federal da Bahia. Salvador, BA, Brasil., Aureliano WA; Instituto de Ciências Sociais, Universidade do Estado do Rio de Janeiro. Rio de Janeiro, RJ, Brasil., Gibbon S; Anthropology Department, University College of London. London, England.

المصدر: Ciencia & saude coletiva [Cien Saude Colet] 2019 Sep 26; Vol. 24 (10), pp. 3637-3650. Date of Electronic Publication: 2019 Sep 26 (Print Publication: 2019).

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Associação Brasileira de Pós-Graduação em Saúde Coletiva Country of Publication: Brazil NLM ID: 9713483 Publication Model: eCollection Cited Medium: Internet ISSN: 1678-4561 (Electronic) Linking ISSN: 14138123 NLM ISO Abbreviation: Cien Saude Colet Subsets: MEDLINE

مواضيع طبية MeSH: Public Health*, Genetic Diseases, Inborn/*diagnosis , Rare Diseases/*diagnosis, Brazil ; Caregivers/statistics & numerical data ; Cities ; Genetic Diseases, Inborn/therapy ; Health Personnel/statistics & numerical data ; Health Services Accessibility ; Humans ; Interviews as Topic ; Patient Compliance ; Rare Diseases/genetics ; Rare Diseases/therapy